1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics 2022 - United Kingdom

Mental Health Analysis & Statistics 2022 - United Kingdom

1-30 of about 100 reports

Epilepsy Devices Market : Segmented by Product ; By End-User and Region – Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030

  • $ 5000
  • September 2021
  • 179 pages

Product overview Epilepsy is a chronic neurological condition that produces repeated unprovoked seizures, which are characterized by undetected episodes of uncontrollable movement involving either a portion ...

  • World
  • North America
  • Neurological Disorder
  • Industry analysis
  • Number Of Enterprises
  • Health Expenditure

Progressive Supranuclear Palsy Therapies Market by Type of Treatment, and Key Geographical Regions : Industry Trends and Global Forecasts, 2021-2030

  • $ 5499
  • August 2021
  • 106 pages

INTRODUCTION The “Progressive Supranuclear Palsy (PSP) Therapies Market by Type of Treatment (Curative and Palliative / Symptomatic), and Key Geographical Regions (US, UK, Germany, France, Italy and ...

  • World
  • Spain
  • Pharmaceutical
  • Clinical Trial
  • Industry analysis

Major Depressive Disorder - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 175 pages

‘Major Depressive Disorder (MDD)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Major Depressive Disorder (MDD), historical and forecasted epidemiology in the United ...

  • Spain
  • France
  • Depression
  • Industry analysis

Anti-Parkinson Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • $ 5000
  • June 2021
  • 175 pages

Major players in the Anti-Parkinson drugs market are GlaxoSmithKline plc, Pfizer, Merck, Novartis, Roche, UCB S.A, Teva Pharmaceuticals, AbbVie Inc. and Mylan. The global anti-parkinson drugs market is ...

  • World
  • United Kingdom
  • Psychotic Disorder
  • Industry analysis

Brain And Neuroimaging Devices Global Market Report 2021: COVID 19 Growth And Change to 2030

  • $ 5000
  • May 2021
  • 175 pages

Major players in the brain and neuroimaging devices market are GE, Siemens, Philips, Canon, Hitachi Medical Systems, Medtronic Plc, EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co., Ltd, and Elekta. The ...

  • World
  • Sweden
  • Neurological Disorder
  • Magnetic Resonance Imaging
  • Industry analysis
  • Diagnostic Imaging Density
  • Medical Technology Density

ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Gaucher disease in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Research And Development
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

PR001 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“PR001 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Gaucher disease in 7 Major Markets. A detailed picture of the PR001 ...

  • Europe
  • Japan
  • Research And Development
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

Spasticity - Epidemiology Forecast to 2030

  • $ 3750
  • February 2021
  • 77 pages

‘Spasticity – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Spasticity, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, ...

  • United States
  • Spain
  • Neurological Disorder
  • Neurology
  • Industry analysis

Traumatic Brain Injury - Epidemiology Forecast to 2030

  • $ 3750
  • February 2021
  • 63 pages

‘Traumatic Brain Injury (TBI)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Traumatic Brain Injury (TBI), historical and forecasted epidemiology in the United States, ...

  • Spain
  • Germany
  • Neurological Disorder
  • Industry analysis

AV-101 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“AV-101 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Major Depressive Disorder in 7 Major Markets. A detailed picture ...

  • Europe
  • World
  • Depression
  • Research And Development
  • Industry analysis
  • Health Expenditure

AXS-05 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“AXS-05 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Treatment Resistant Depression in 7 Major Markets. A detailed ...

  • Europe
  • World
  • Depression
  • Research And Development
  • Industry analysis
  • Health Expenditure

REL-1017 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“REL-1017 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Major Depressive Disorder in 7 Major Markets. A detailed picture ...

  • Europe
  • World
  • Depression
  • Therapy
  • Industry analysis
  • Health Expenditure

SELTOREXANT- Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“SELTOREXANT- Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Major Depressive Disorder in 7 Major Markets. A detailed picture ...

  • Europe
  • World
  • Depression
  • Anesthetics
  • Industry analysis
  • Health Expenditure

Fintepla (ZX008) - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“Fintepla (ZX008)- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Lennox Gastaut Syndrome in 7 Major Markets. A detailed ...

  • Europe
  • World
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

TAK935 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“TAK935- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Lennox Gastaut Syndrome in 7 Major Markets. A detailed picture ...

  • Europe
  • World
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

Perampanel - Emerging Insights and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“Perampanel- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Lennox Gastaut Syndrome in 7 Major Markets. A detailed picture ...

  • Europe
  • World
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

Hepatic Encephalopathy - Epidemiology Forecast to 2030

  • $ 3750
  • February 2021
  • 90 pages

‘Hepatic Encephalopathy—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Hepatic Encephalopathy epidemiology in the United States, ...

  • United States
  • Spain
  • Neurological Disorder
  • Industry analysis

Excessive Daytime Sleepiness (EDS) - Epidemiology Forecast to 2030

  • $ 3750
  • January 2021
  • 80 pages

‘Excessive Daytime Sleepiness (EDS)-Epidemiology Forecast–2030’ report delivers an in-depth understanding of the EDS, historical and forecasted epidemiology as well as the EDS trends in the United ...

  • United States
  • France
  • Epidemiology
  • Bipolar Disorder
  • Industry analysis

Multiple System Atrophy (MSA) - Epidemiology Forecast to 2030

  • $ 3750
  • January 2021
  • 80 pages

‘Multiple System Atrophy (MSA)-Epidemiology Forecast–2030’ report delivers an in-depth understanding of the MSA, historical and forecasted epidemiology as well as the MSA trends in the United States, ...

  • Japan
  • United States
  • Epidemiology
  • Neurological Disorder
  • Industry analysis

Spinal Cord Injury (SCI) - Epidemiology forecast- 2030

  • $ 3750
  • January 2021
  • 80 pages

‘Spinal Cord Injury- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical, and forecasted Spinal Cord Injury epidemiology in the 7MM, i.e., the United ...

  • United States
  • Japan
  • Neurological Disorder
  • Industry analysis

Wilson’s Disease (WD) – Epidemiology Forecast – 2030

  • $ 3750
  • January 2021
  • 80 pages

‘Wilson’s Disease (WD) – Epidemiology Forecast – 2030’ report delivers an in-depth understanding of and historical and forecasted epidemiology of Wilson’s disease (WD) in the United States, ...

  • Spain
  • Japan
  • Neurological Disorder
  • Industry analysis

Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030

  • $ 3750
  • December 2020
  • 60 pages

‘Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Adrenoleukodystrophy epidemiology in the 7MM, i.e., ...

  • France
  • Germany
  • Neurological Disorder
  • Epidemiology
  • Industry analysis

Chemotherapy Induced Peripheral Neuropathy (CIPN) - Epidemiology Forecast–2030

  • $ 3750
  • December 2020
  • 55 pages

‘Chemotherapy Induced Peripheral Neuropathy (CIPN) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the CIPN, historical and forecasted epidemiology as well as the CIPN ...

  • United States
  • Japan
  • Epidemiology
  • Neurological Disorder
  • Industry analysis

West Syndrome - Epidemiology Forecast - 2030

  • $ 3750
  • September 2020
  • 100 pages

‘West Syndrome - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted West Syndrome epidemiology in the United States, EU5 (Germany, Spain, ...

  • United States
  • Spain
  • Epidemiology
  • Neurological Disorder
  • Industry analysis

West Syndrome - Epidemiology Forecast - 2030

  • $ 3750
  • September 2020
  • 100 pages

‘West Syndrome - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted West Syndrome epidemiology in the United States, EU5 (Germany, Spain, ...

  • United States
  • Spain
  • Epidemiology
  • Neurological Disorder
  • Industry analysis

AAV2/8 LSPHGAA - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“AAV2/8 LSPHGAA - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Pompe Disease in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

AT845 - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“AT845 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Pompe Disease in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

AVR RD 01 - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“AVR RD 01 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Fabry Disease in 7 Major Markets. A detailed picture ...

  • Europe
  • World
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

FLT190 - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“FLT190 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Fabry Disease in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Neurological Disorder
  • Therapy
  • Industry analysis
  • Health Expenditure

Lenti-D- Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“Lenti-D- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Cerebral Adrenoleukodystrophy (CALD) in 7 Major Markets. ...

  • Europe
  • Japan
  • Research And Development
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on